世界のうっ血性心不全（CHF）治療用装置市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Congestive Heart Failure (CHF) Treatment Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z03704 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、うっ血性心不全（CHF）治療用装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。うっ血性心不全（CHF）治療用装置の種類別市場規模（心臓再同期療法（CRT）、植込み型除細動器（ICD））、用途別市場規模（左心室補助装置（LVAD）、右心室補助装置（RVAD）、両心室補助装置（BIVAD））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・うっ血性心不全（CHF）治療用装置の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abiomed、Berlin Heart GmbH、Biotronik SE & Co. KG、Boston Scientific Corporation、HeartWare International、Jarvik Heart、LivaNova PLC、Medtronic、ReliantHeart、Abbott ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：心臓再同期療法（CRT）、植込み型除細動器（ICD） ・用途別分析2016年-2026年：左心室補助装置（LVAD）、右心室補助装置（RVAD）、両心室補助装置（BIVAD） ・うっ血性心不全（CHF）治療用装置の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・うっ血性心不全（CHF）治療用装置のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・うっ血性心不全（CHF）治療用装置のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・うっ血性心不全（CHF）治療用装置の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・うっ血性心不全（CHF）治療用装置の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Congestive Heart Failure (CHF) Treatment Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Congestive Heart Failure (CHF) Treatment Devices size is estimated to be xx million in 2020 from USD 5114.7 million in 2019, with a change of XX% between 2019 and 2020. The global Congestive Heart Failure (CHF) Treatment Devices market size is expected to grow at a CAGR of 3.0% for the next five years.

Market segmentation
Congestive Heart Failure (CHF) Treatment Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)

Market segment by Application can be divided into
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)

The key market players for global Congestive Heart Failure (CHF) Treatment Devices market are listed below:
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Congestive Heart Failure (CHF) Treatment Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cardiac Resynchronization Therapy (CRT)
1.2.3 Implantable Cardioverter Defibrillators (ICDs)
1.3 Market Analysis by Application
1.3.1 Overview: Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Left Ventricular Assist Device (LVAD)
1.3.3 Right Ventricular Assist Device (RVAD)
1.3.4 Biventricular Assist Device (BIVAD)
1.4 Global Congestive Heart Failure (CHF) Treatment Devices Market Size & Forecast
1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Value (2016-2026))
1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Volume (2016-2026)
1.4.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity Analysis
1.5.1 Global Congestive Heart Failure (CHF) Treatment Devices Total Production Capacity (2016-2026)
1.5.2 Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Congestive Heart Failure (CHF) Treatment Devices Market Drivers
1.6.2 Congestive Heart Failure (CHF) Treatment Devices Market Restraints
1.6.3 Congestive Heart Failure (CHF) Treatment Devices Trends Analysis
2 Manufacturers Profiles
2.1 Abiomed
2.1.1 Abiomed Details
2.1.2 Abiomed Major Business
2.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Berlin Heart GmbH
2.2.1 Berlin Heart GmbH Details
2.2.2 Berlin Heart GmbH Major Business
2.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Biotronik SE & Co. KG
2.3.1 Biotronik SE & Co. KG Details
2.3.2 Biotronik SE & Co. KG Major Business
2.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business
2.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 HeartWare International
2.5.1 HeartWare International Details
2.5.2 HeartWare International Major Business
2.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Jarvik Heart
2.6.1 Jarvik Heart Details
2.6.2 Jarvik Heart Major Business
2.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 LivaNova PLC
2.7.1 LivaNova PLC Details
2.7.2 LivaNova PLC Major Business
2.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Medtronic
2.8.1 Medtronic Details
2.8.2 Medtronic Major Business
2.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 ReliantHeart
2.9.1 ReliantHeart Details
2.9.2 ReliantHeart Major Business
2.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Product and Services
2.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturer
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Congestive Heart Failure (CHF) Treatment Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Congestive Heart Failure (CHF) Treatment Devices Manufacturer Market Share
3.4.2 Top 6 Congestive Heart Failure (CHF) Treatment Devices Manufacturer Market Share
3.5 Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Congestive Heart Failure (CHF) Treatment Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2026)
4.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026)
4.3 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026)
4.4 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026)
4.5 South America Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026)
4.6 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Type (2016-2026)
5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2016-2026)
5.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Application (2016-2026)
6.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2016-2026)
6.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2026)
7.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2026)
7.3 North America Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
7.3.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2026)
8.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2026)
8.3 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
8.3.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size by Region
9.3.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2026)
10.2 South America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2026)
10.3 South America Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
10.3.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
11.3.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Congestive Heart Failure (CHF) Treatment Devices Typical Distributors
12.3 Congestive Heart Failure (CHF) Treatment Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Abiomed Basic Information, Manufacturing Base and Competitors
Table 4. Abiomed Major Business
Table 5. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 6. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Berlin Heart GmbH Basic Information, Manufacturing Base and Competitors
Table 8. Berlin Heart GmbH Major Business
Table 9. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 10. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biotronik SE & Co. KG Basic Information, Manufacturing Base and Competitors
Table 12. Biotronik SE & Co. KG Major Business
Table 13. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 14. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Boston Scientific Corporation Major Business
Table 17. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 18. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. HeartWare International Basic Information, Manufacturing Base and Competitors
Table 20. HeartWare International Major Business
Table 21. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 22. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Jarvik Heart Basic Information, Manufacturing Base and Competitors
Table 24. Jarvik Heart Major Business
Table 25. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 26. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. LivaNova PLC Basic Information, Manufacturing Base and Competitors
Table 28. LivaNova PLC Major Business
Table 29. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 30. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Medtronic Basic Information, Manufacturing Base and Competitors
Table 32. Medtronic Major Business
Table 33. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 34. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. ReliantHeart Basic Information, Manufacturing Base and Competitors
Table 36. ReliantHeart Major Business
Table 37. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 38. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Abbott Basic Information, Manufacturing Base and Competitors
Table 40. Abbott Major Business
Table 41. Abbott Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 42. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Congestive Heart Failure (CHF) Treatment Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Congestive Heart Failure (CHF) Treatment Devices Production Site of Key Manufacturer
Table 48. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021e) & (K Units)
Table 49. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2021-2026) & (K Units)
Table 50. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 53. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 54. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 59. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 60. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 65. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 66. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 69. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 70. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 71. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 72. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 74. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 78. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 88. South America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 89. South America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 90. South America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 93. South America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 94. South America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 95. South America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Congestive Heart Failure (CHF) Treatment Devices Typical Distributors
Table 107. Congestive Heart Failure (CHF) Treatment Devices Typical Customers
List of Figures
Figure 1. Congestive Heart Failure (CHF) Treatment Devices Picture
Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2020
Figure 3. Cardiac Resynchronization Therapy (CRT)
Figure 4. Implantable Cardioverter Defibrillators (ICDs)
Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2020
Figure 6. Left Ventricular Assist Device (LVAD)
Figure 7. Right Ventricular Assist Device (RVAD)
Figure 8. Biventricular Assist Device (BIVAD)
Figure 9. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales (2016-2026) & (K Units)
Figure 31. Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity (2016-2026) & (K Units)
Figure 32. Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Congestive Heart Failure (CHF) Treatment Devices Market Drivers
Figure 34. Congestive Heart Failure (CHF) Treatment Devices Market Restraints
Figure 35. Congestive Heart Failure (CHF) Treatment Devices Market Trends
Figure 36. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturer in 2020
Figure 37. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Manufacturer in 2020
Figure 38. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Congestive Heart Failure (CHF) Treatment Devices Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Congestive Heart Failure (CHF) Treatment Devices Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2026)
Figure 42. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2026)
Figure 43. North America Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 44. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 46. South America Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 48. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 49. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2016-2026)
Figure 50. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 52. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2016-2026)
Figure 53. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 55. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 56. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 57. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 58. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 59. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 60. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 61. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 66. South America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 67. South America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 68. South America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 69. South America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

---